The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Cosmo Becomes Largest Shareholder of Paion (2016-06-24)
> Cosmo to make EUR 10 million upfront license fee payment to PAION > PAION entitled to receive up to EUR 42.5 million in milestone payments and significant double-digit tiered royalties > PAION resolves issuance of 5,064,194 new shares to a subsidiary of Cos...
- CRISPR Therapeutics Raises Additional $38m in Series B (2016-06-24)
Funding to Support the Development of its CRISPR/Cas9 Gene-Editing Platform and Programs CRISPR Therapeutics, a biopharmaceutical company focused on translating CRISPR/Cas9 gene-editing technology into transformative medicines, today announced an additional $3...
- Qiagen Completes Tender Offer for Shares in Exiqon A/S (2016-06-23)
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the successful completion of the conditional, voluntary public tender offer for the shares in Exiqon A/S, a world leader in RNA technology. The extended Offer Period expired yesterday, on 22 ...
- Qiagen Joins Consortium to Map Microbial Genomes in Cities (2016-06-21)
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration with Weill Cornell Medicine in a global study seeking insights on the prevalence of pathogens, including antimicrobial resistance, in urban environments. Starting today, resea...
- Bruker Acquires Software Assets for Minerals Analysis (2016-06-20)
Bruker today announced that it has acquired the assets of Yingsheng Technology Pty Ltd. in Brisbane, Australia, that relate to the 3rd generation Advanced Mineral Identification and Characterization System (AMICS) software package, and respective IP for advanced mi...
- F2G Ltd Announces $60m Financing Round Led by Sectoral Asset (2016-06-20)
Funding to Take Lead Compound Through to Product Approval and Development of Pipeline Assets F2G Ltd, the UK-based antifungal drug discovery and development company, today announced that it has raised $60 million in financing to develop its pipeline of novel t...
- Sygnis: Detection, Amplification of Cell- free DNA in Blood (2016-06-17)
> New tool is based on SYGNIS’ TruePrime technology > Enables the early detection of cancer using a blood sample instead of tissue biopsies > Several top-level collaborations with hospitals and research centers in Europe and the US established to further deve...
- Forbion Supports €22m Series B Round of Allecra Therapeutics (2016-06-16)
Funding to accelerate Phase 2 Development of Novel Antibiotic to Treat Resistant Gram-negative Bacterial Infections in the Hospital Forbion Capital Partners, the Dutch life sciences venture capital firm, today announced that it has invested from its recent FCF...
- Bruker and US CDC: New Reference Library for MALDI Biotyper (2016-06-16)
At the American Society for Microbiology (ASM) Microbe 2016 conference, Bruker today announces the results of a successful collaboration with the Special Bacteriology Reference Laboratory at the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Geor...
- Jörn Aldag Appointed CEO of Hookipa Biotech (2016-06-16)
Hookipa Biotech AG, a company pioneering a new class of immunotherapies and vaccines, today announces the appointment of Mr. Jörn Aldag as CEO. Mr. Aldag brings significant leadership experience and sector knowledge to Hookipa from leading biotechnology companie...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to email@example.com and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)